ELISA microarray technology as a high-throughput system for cancer biomarker validation

Expert Review of Proteomics

Volumn 3, Issue 1, 2006, Pages 37-44

  Zangar, Richard C ^a   Daly, Don S ^a   White, Amanda M ^a  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

Antibody; Biomarkers; Cancer; Detection; ELISA; Microarray; Normalization; Profile; Quality control; Statistics

Indexed keywords

BIOLOGICAL MARKER; BUFFER; REAGENT;

CANCER SCREENING; CANCER STAGING; CONFERENCE PAPER; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HEALTH CARE UTILIZATION; INFORMATION PROCESSING; MEDICAL ASSESSMENT; PROTEIN MICROARRAY; QUALITY CONTROL; REPRODUCIBILITY; VALIDATION STUDY;

BUFFERS; CALIBRATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MICROARRAY ANALYSIS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 33646145881     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.3.1.37     Document Type: Conference Paper

References (39)

1. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 1, 845-867 (2002).
2. Wadlow R, Ramaswamy S. DNA microarrays in clinical cancer research. Curr. Mol. Med. 5, 111-120 (2005).
3. Zangar RC, Varnum SM, Bollinger N. Studying cellular processes and detecting disease with protein microarrays. Drug Metab. Rev. 37, 473-487 (2005). • Detailed discussion and comparison of the current approaches and applications for protein microarrays.
4. Zhou M, Conrads TP, Veenstra TD. Proteomics approaches to biomarker detection. Brief. Funct. Genomic. Proteomic. 4, 69-75 (2005).
5. Banez LL, Srivastava S, Moul JW. Proteomics in prostate cancer. Curr. Opin. Urol. 15, 151-156 (2005).
6. Umar A, Srivastava S. The promise of biomarkers in colorectal cancer detection. Dis. Markers 20, 87-96 (2004).
7. Schulte I, Tammen H, Selle H, Schulz-Knappe P. Peptides in body fluids and tissues as markers of disease. Expert Rev. Mol. Diagn. 5, 145-157 (2005).
8. Davidsson P, Sjogren M. The use of proteomics in biomarker discovery in neurodegenerative diseases. Dis. Markers 21, 81-92 (2005).
9. Merrick BA, Bruno ME. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity. Curr. Opin. Mol. Ther. 6, 600-607 (2004).
10. Chen R, Pan S, Brentnall TA, Aebersold R. Proteomic profiling of pancreatic cancer for biomarker discovery. Mol. Cell. Proteomics 4, 523-533 (2005).
11. Drake RR, Cazare LH, Semmes OJ, Wadsworth JT. Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers. Expert Rev. Mol. Diagn. 5, 93-100 (2005).
12. Torabian S, Kashani-Sabet M. Biomarkers for melanoma. Curr. Opin. Oncol. 17, 167-171 (2005).
13. Ho L, Sharma N, Blackman L, Festa E, Reddy G, Pasinetti GM. From proteomics to biomarker discovery in Alzheimer's disease. Brain Res. Brain Res. Rev. 48, 360-369 (2005).
14. Powell K. Proteomics delivers on promise of cancer biomarkers. Nature Med. 9, 980 (2003).
15. Verma M, Srivastava S. New cancer biomarkers deriving from NCI early detection research. Recent Results Cancer Res. 163, 72-84 (2003).
16. Anderson NL. The roles of multiple proteomics platforms in a pipeline for new diagnostics. Mol. Cell. Proteomics 4(10), 1441-1444 (2005). • Discussion of the issues and problems facing the development of new protein biomarkers for use in the clinic.
17. Schweitzer B, Kingsmore SF. Measuring proteins on microarrays. Curr. Opin. Biotechnol. 13, 14-19 (2002).
18. Haab BB. Methods and applications of antibody microarrays in cancer research. Proteomics 3, 2116-2122 (2003).
19. Nielsen UB, Geierstanger BH. Multiplexed sandwich assays in microarray format. J. Immunol. Methods 290, 107-120 (2004).
20. Pavlickova P, Schneider EM, Hug H. Advances in recombinant antibody microarrays. Clin. Chim. Acta 343, 17-35 (2004).
21. Huang RP. Simultaneous detection of multiple proteins with an array-based enzyme-linked immunosorbent assay (ELISA) and enhanced chemiluminescence (ECL). Clin. Chem. Lab. Med. 39, 209-214 (2001).
22. Woodbury RL, Varnum SM, Zangar RC. Elevated HGF levels in sera from breast cancer patients detected using a protein microarray ELISA. J. Proteome Res. 1, 233-237 (2002).
23. Schweitzer B, Wiltshire S, Lambert J et al. Inaugural article: immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection. Proc. Natl Acad. Sci. USA 97, 10113-10119 (2000).
24. Saviranta P, Okon R, Brinker A, Warashina M, Eppinger J, Geierstanger BH. Evaluating sandwich immunoassays in microarray format in terms of the ambient analyte regime. Clin. Chem. 50, 1907-1920 (2004).
25. Liszewski K. Advances in protein arrays overcome obstacles. Genet. Eng. News 25, 40-43 (2005).
26. Haab BB, Geierstanger BH, Michailidis G et al. Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: systematic variation between sample types and calibration of mass spectrometry data. Proteomics 5, 3278-3291 (2005). • Multi-institutional comparison of the different types of antibody microarrays.
27. Daly DS, White AM, Varnum SM, Anderson KK, Zangar RC. Evaluating concentration estimation errors in ELISA microarray experiments. BMC Bioinformatics 6, 17 (2005). • First publication of an open-source software specifically designed to aid in the high-throughput analysis of enzyme-linked immunosorbent assay microarray microarray data.
28. Conrad U, Scheller J. Considerations on antibody-phage display methodology. Comb. Chem. High Throughput. Screen. 8, 117-126 (2005).
29. Siegel RW, Coleman JR, Miller KD, Feldhaus MJ. High efficiency recovery and epitope-specific sorting of an scFv yeast display library. J. Immunol. Methods 286, 141-153 (2004).
30. Lopez MF, Pluskal MG. Protein micro- and macroarrays: digitizing the proteome. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 787, 19-27 (2003).
31. Wang XL, Li F, Su YH et al. Ultrasensitive detection of protein using an aptamer-based exonuclease protection assay. Anal. Chem. 77, 2278 (2005).
32. Shi L, Tong W, Goodsaid F et al. QA/QC: challenges and pitfalls facing the microarray community and regulatory agencies. Expert Rev. Mol. Diagn. 4, 761-777 (2004). • Review of the problems that have hampered the clinical use of DNA microarray data.
33. Quackenbush J. Microarray data normalization and transformation. Nature Genet. 32(Suppl.), 496-501 (2002). • Overview of the most common approaches for normalizing DNA microarray data.
34. Kroll TC, Wolfl S. Ranking: a closer look on globalisation methods for normalisation of gene expression arrays. Nucleic Acids Res. 30, e50 (2002).
35. Grant GR, Manduchi E, Pizarro A, Stoeckert CJ Jr. Maintaining data integrity in microarray data management. Biotechnol. Bioeng. 84, 795-800 (2003).
36. Yang YH, Dudoit S, Luu P et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30, e15 (2002).
37. Finkelstein D, Ewing R, Gollub J, Sterky F, Cherry JM, Somerville S. Microarray data quality analysis: lessons from the AFGC project. Arabidopsis Functional Genomics Consortium. Plant Mol. Biol. 48, 119-131 (2002).
38. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J. Clin. 50, 7-33 (2000).
39. Lea JS, Miller DS. Optimum screening interventions for gynecologic malignancies. Tex. Med. 97, 49-55 (2001).